Cyclosporine Plus Methotrexate or Alemtuzumab
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- José Antonio Pérez-Simón, MD, PhD
University of Salamanca
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Propedeutic Oncology, Medical University of Gdansk
Gdansk, Poland
- Clinical Hematology Department. Ico-Hospital Germans Trias I Pujol. Jose Carreras Research Institute
Badalona, Barcelona, Spain
- Hospital Clinic I Provincial
Barcelona, Spain
- Santa Creu I Sant Pau Hospital
Barcelona, Spain
- Hospital Universitario de Salamanca
Salamanca, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2003
- Primary completion
- 30 Nov 2009
- Completion
- 30 Nov 2009
- Last update posted
- 29 Dec 2017
- Registered enrollment
- 72
- Registry id
- NCT02701517
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.